Suppressive effect of maslinic acid on PMA-induced protein kinase C in human B-lymphoblastoid cells

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 4, 2012, Pages 1177-1182

  Mooi, Lim Yang ^a   Yew, Wong Teck ^a   Hsum, Yap Wei ^b   Soo, Khoo Kong ^b   Hoon, Lim Saw ^c   Chieng, Yeo Chew ^d  

^a UNIVERSITI TUNKU ABDUL RAHMAN   (Malaysia)

^b Jalan Universiti   (Malaysia)

^c MONASH UNIVERSITY   (Australia)

^d UNIVERSITI SULTAN ZAINAL ABIDIN   (Malaysia)

Author keywords

Cancer chemoprevention; Maslinic acid; PMA; Protein kinase C; Raji cell s

Indexed keywords

1 (5 ISOQUINOLINESULFONYL) 2 METHYLPIPERAZINE; ACETOPHENONE DERIVATIVE; ANTINEOPLASTIC AGENT; BENZOPYRAN DERIVATIVE; ENZYME INHIBITOR; ISOENZYME; MASLINIC ACID; OLEANOLIC ACID; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C; ROTTLERIN; SPHINGOSINE; STAUROSPORINE; TRITERPENE; URSOLIC ACID;

ARTICLE; CELL CULTURE; DRUG EFFECT; ENZYMOLOGY; HUMAN; IC 50; ISOLATION AND PURIFICATION; METABOLISM; PRE B LYMPHOCYTE;

1-(5-ISOQUINOLINESULFONYL)-2-METHYLPIPERAZINE; ACETOPHENONES; ANTICARCINOGENIC AGENTS; BENZOPYRANS; CELLS, CULTURED; ENZYME INHIBITORS; HUMANS; INHIBITORY CONCENTRATION 50; ISOENZYMES; OLEANOLIC ACID; PRECURSOR CELLS, B-LYMPHOID; PROTEIN KINASE C; SPHINGOSINE; STAUROSPORINE; TETRADECANOYLPHORBOL ACETATE; TRITERPENES;

EID: 84873021362     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.4.1177     Document Type: Article

References (38)

1. Barry OP, Kazanietz MG (2001). Protein kinase C isozymes, novel phorbol ester receptors and cancer chemotherapy. Curr Pharm Des, 7, 1725-44.
2. Boone CW, Kelloff GJ, Malone WE (1990). Identification of candidate cancer chemoprevention agents and their evaluation in animal models and human clinical trials: a review. Cancer Res, 50, 2-9.
3. Butler AP, Mar PK, McDonald FF, et al (1991). Involvement of protein kinase C in the regulation of ornithine decarboxylase mRNA by phorbol esters in rat hepatoma cells. Experimental Cell Research, 194, 56-61.
4. Brick-Ghannam C, Ericson ML, Schelle I, et al (1994). Differential regulation of mRNAs encoding protein kinase C isoenzymes in activated human B cells. Hum Immunol, 41, 216-24.
5. Chang PL, Tucker MA, Hicks PH, Prince CW (2002). Novel protein kinase C isoforms and mitogen-activated kinase kinase mediate phorbol ester-induced osteopontin expression. Int J Biochem Cell Biol, 34, 1142-51.
6. Chang J, Carvalho C, Mori S, et al (2009). A genomic strategy to elucidate modules of oncogenic pathway signaling networks. Molecular Cell, 34, 104-14.
7. Chaturvedi PK, Bhui K, Shukla Y (2008). Lupeol: Connotations for chemoprevention. Cancer Lett, 263, 1-13.
8. Dempsey EC, Newton AC, Mochly-Rosen D, et al (2000). Protein kinase C isozymes and the regulation of diverse cell responses. Am J Physiol Lung Cell Mol Physiol, 279, 429-38.
9. Ferlay J, Bray F, Pisani P, et al (2004). Globocan 2002: Cancer Incidence, Mortality and Prevalence Worldwide, Version 2.0: IARC CancerBase no.5. Lyon, IARC Press.
10. Greenwald P, Kelloff GJ (1996). The role of chemoprevention in cancer control. In: Principles of chemoprevention, edited by Stewart BW, McGregor D and Kleihues P. IARC scientific publications no. 139. International agency for research on cancer, Lyon, 1996, pp 13-22.
11. Griner EM, Kazanietz MG (2007). Protein Kinase C and other diacylglycerol effectors in cancer. Nat Rev Cancer, 7, 281-94.
12. Guillen N, Acin S, Surra JC, et al (2009). Apolipoprotein E determines the hepatic transcriptional profile of dietary maslinic acid in mice. J Nutr Biochem, 20, 882-93.
13. Hsum YW, Yew WT, Lim PVH, et al (2011). Cancer chemopreventive activity of maslinic acid: suppression of COX-2 expression and inhibition of NF-?B and AP-1 activation in Raji cells. Planta Med, 77, 152-7.
14. Kanashiro CA, Khalil RA (1998). Signal transduction by protein kinase C in mammalian cells. Clin Exp Pharmacol Physiol, 25, 974-85.
15. Kelloff GJ, Boone CW, Crowell JA, et al (1996). New agents for cancer chemoprevention. J Cell Biochem, 26, 1-28.
16. Kelloff GJ, Hawk ET, Karp JE, et al (1997). Progress in clinical chemoprevention. Semin Oncol, 24, 241-52.
17. Kelloff GJ, Sigman CC, Greenwald P (1999a). Cancer chemoprevention: progress and promise. Eur J Cancer, 35, 1755-62.
18. Kelloff GJ (1999b). Perspectives on cancer chemoprevention research and drug development. Adv Cancer Res, 78, 199-334.
19. Kim YK, Yoon SK, Ryu SY (2000). Cytotoxic triterpenes from stem bark of Physocarpus intermedius. Planta Med, 66, 485-6.
20. Kim Y, Kim K, Lee H, et al (2009). Celastrol binds to ERK and inhibits FceRI signaling to exert an anti-allergic effect. Eur J Pharmacol, 612, 131-42.
21. Kwon MJ, Soh JW, Chang CH (2006). Protein kinase Cd is essential to maintain CIITA gene expression in B Cells. J Immunol, 177, 950-6.
22. Li C, Yang Z, Zhai C, et al (2010). Maslinic acid potentiates the anti-tumor activity of tumor necrosis factor a by inhibiting NF-?B signaling pathway. Mol Cancer, 9, 73.
23. Lim YM, Norhanom AW, Nordin HL, et al (2010). Chemopreventive property of phytosterols and maslinic acid extracted from Coleus tuberosus in inhibiting the expression of EBV-early antigen in Raji cells, Chemistry Biodiversity, 7, 1267-75.
24. Malone WF (1992). Drug development status of four leading chemopreventive agents at the national cancer institute. In: Cancer chemoprevention, edited by Wattenberg LW, Lipkin M, Boone CW and Kelloff GJ Printed in the United States of America, pp 597-606.
25. Martín MA, Vázquez R, Arche A, et al (2006). Suppressive effect of maslinic acid from pomace olive oil on oxidative stress and cytokine production in stimulated murine macrophages. Free Radic Res, 40, 295-302.
26. Medeiros R, Otuki M F, Avellar MCW, et al (2007). Mechanisms underlying the inhibitory actions of the pentacyclic triterpene a-amyrin in the mouse skin inflammation induced by phorbol ester 12-O-tetradecanoylphorbol-13-acetate. Eur J Pharmacol, 559, 227-35.
27. Morrow TA, Muljo SA, Zhang J, et al (1999). Pro-B-cell-specific transcription and proapoptotic function of protein kinase Ceta. Mol Cell Biol, 19, 5608-18.
28. Morse MA, Stoner GD (1993). Cancer chemoprevention: principles and prospects. Carcinogenesis, 4, 1737-46. Nelson T (2007). Cancers Treatments, Chapter 4: Herbal treatments. Unconventional Cancers Tratments. http;//www. miracleii-4u.com/cancer-herbal-treatments. htm. (Accessed on 14 June 2009)
29. Nishizuka Y (1984). The role of Protein Kinase C in cell surface signal transduction and tumour promotion. Nature, 308, 693-8.
30. Prades J, Vögler O, Alemany R, et al (2011). Plant pentacyclic triterpenic acids as modulators of lipid membrane physical properties. Biochim Biophys Acta, 1808, 752-60.
31. Reyes FJ, Centelles J, Lupianez JA, et al (2006). (2a,3b)-2,3- Dihydroxyolean-12-en-28-oic acid, a new natural triterpene from Olea europea, induces caspase dependent apoptosis selectively in colon adenocarcinoma cells. FEBS Lett, 580, 6302-10.
32. Ruddon RW (2007). Cancer Biology. New York: Oxford University Press.
33. Sharkey NA, Leach KL, Blumberg PM (1984). Competitive inhibition by diacylglycerol of specific phorbol ester binding. Proc Natl Acad Sci, 81, 607-10.
34. Subbaramaiah K, Michaluart P, Sporn MB, Dannenberg AJ (2000). Ursolic acid inhibits cyclooxygenase-2 transcription in human mammary epithelial cells. Cancer Res, 60, 2399-404.
35. Savelyeva L and Schwab M (2001). Amplification of oncogenes revisited: from expression profiling to clinical application. Cancer Lett, 167, 115-23.
36. th edition. The McGraw Hill Companies, Inc.
37. Ventura C, Maioli M (2001). Protein kinase C control of gene expression. Crit Rev Eukaryot Gene Expr, 11, 243-67.
38. Wang BH, Polya GM (1996). Selective inhibition of cyclic AMPdependent protein kinase by amphiphilic triterpenoids and related compounds. Phytochemistry, 41, 55-63.